Skip to content
Screener

EyePoint, Inc. EYPT Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$266.8M+13.8%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$20.54M-13.9%
KLR
Kalaris TherapeuticsKLRS
$1.41M
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$16.05M+4,963%
Bausch + Lomb logo
Bausch + LombBLCO
$163M+7.2%

Other financials

Income statement

See full
Revenue$507.0K-90.5%
Gross profit$9.8M-30.1%
Operating income-$97.4M-56.5%
Net income-$94.5M-59.0%
EPS (diluted)-$1.09-28.2%

Balance sheet

See full
Cash & equivalents$110.5M+55.3%
Total debt$22.4M-5.7%
Total equity$166.4M-32.4%
Total assets$228.2M-24.2%

Cash flow

See full
Operating cash flow-$62.3M+0.4%
CapEx$1.2M-1.6%
Free cash flow-$63.5M+0.4%

Valuation

See full
Market cap$1.13B+59.1%
Enterprise value$1.04B+57.2%
P/S404×+390×

Profitability

See full
Operating margin-11,365.2%-11,754pp
Net margin-10,994.7%-11,355pp
FCF margin-9,726.7%-10,132pp

Returns & leverage

See full
Return on equity-148.7%-13,871pp
Debt / equity0.1×0.0×
Current ratio4.5×-3.5×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The source filing: EyePoint, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335037
Line itemJune 30, 2026December 31, 2025
Other current liabilities – operating lease current portion$2,553$2,022
Operating lease liabilities – noncurrent portion19,81420,772
Total operating lease liabilities$22,367$22,794

Item 1. Unaudited Financial Statements

FAQ

What is EyePoint, Inc.'s operating lease liabilities (total)?
EyePoint, Inc. (EYPT) reported operating lease liabilities (total) of $22.37M in Q2 2026.
How has EyePoint, Inc.'s operating lease liabilities (total) changed year-over-year?
EyePoint, Inc.'s operating lease liabilities (total) decreased by 5.7% year-over-year, from $23.72M to $22.37M.
What is the long-term trend for EyePoint, Inc.'s operating lease liabilities (total)?
Over 5 years (2020 to 2025), EyePoint, Inc.'s operating lease liabilities (total) has grown at a 51.1% compound annual growth rate (CAGR), from $2.9M to $22.79M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.

Ask your AI about EyePoint, Inc.'s operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude